Chief Executive Officer
Oliver is a experienced business leader with a strong technical background and has worked at the leading edge of the point of care diagnostics industry for over 30 years. He has held key positions in numerous start-ups and Blue-Chip multinationals and has a recognised track record of bringing category defining and disruptive Point of Care diagnostics products to market.
Prof Damion Corrigan
Founder & Chief Technical Officer
Prof Damion is a founder of Aureum and inventor of the first two Aureum IP filings. He also holds an academic position as LGC Professor in Measurement Science for Health in the Department of Pure and Applied Chemistry at the University of Strathclyde. His academic research focuses on development of new electrochemical biosensors and their application towards the diagnostic challenges faced in modern healthcare provision.
Prof Steve Howell
Non Executive Chairman
Steve joins Aureum Diagnostics as a non executive Chairman where he has over twenty five years’ life science and diagnostics experience. His passion is helping build and grow companies bringing them to profitability and supporting management teams to build great businesses of which they can be proud.Read More
Dr John Shillingford
Clinical Trial and Regulatory Adviser
Dr John Shillingford, PhD, holds both a B.Sc. in Biochemistry and a Ph.D. in Biochemical Pharmacology from the University of Surrey.
For the past eight years John has provided a consultancy service to global firms on the development of clinical drug trials and MedTech devices.Read More
Chief Operating Officer
As chief operating officer at Aureum, Tessa Ogle is responsible for the operations of the company. She brings more than 17 years of experience to Aureum. Her experience and leadership have been focused on developing and delivering technology-driven business services and solutions, providing outstanding client service, and driving profitable revenue growth.Read More
Dr Richard Bowker
Director of Research and Development
Dr Richard Bowker is responsible for overseeing all aspects of research and development within Aureum. He leads a team of researchers who are working together to develop Aureum’s breakthrough point of care diagnostics platform to meet rapidly evolving global healthcare needs. Richard holds a PhD in Epigenetics and has over 10 years experience in developing point of care diagnostics.Read More
Professor David Onions
David Onions, PhD FMedSCi DVMS(hon) FRSA FRSE, is an investor in biomedical companies and former Chief Medical Officer of Invitrogen/Life Technologies (now Thermo Fisher). He founded 2 biotechnology companies (Q-One Biotech and BioOutsource) which exited for a total of $100M and was involved in the buy-out of BioReliance which acquired by Sigma-Aldrich (now Merck KGaA).Read More